Metabolic syndrome prevalence in Iran: a systematic review and meta-analysis
Journal of Kermanshah University of Medical Sciences: July 30, 2014, 18 (4); e74115
July 29, 2014
Article Type: Research Article
February 16, 2014
July 01, 2014
F , Sayehmiri
S. Metabolic syndrome prevalence in Iran: a systematic review and meta-analysis,
J Kermanshah Univ Med Sci.
Background: Metabolic syndrome (MetS) is a complex of risk factors which increase the risk of cardiovascular diseases, type 2 diabetes, morbidity and mortality in people. The aim of this study was to analyze the prevalence of MetS in Iran using a meta-analysis study.
Methods: The SID, Magiran, Irandoc, Medlib, Google Scholar and PubMed databases were searched for MetS prevalence. 26 articles conducted between 2003 and 2013 in Iran were selected and the obtained data were analyzed by a meta-analysis using random-effects model. Heterogeneity was assessed using I2 statistics. Data were analyzed by R software and STATA (Ver. 11.2).
Results: The total sample size was 60635 people with the age range of 3-90 years. The metabolic syndrome prevalence based on IDF definition was 36% (95% CI: 0.32-0.40) and based to ATPIII was 27% (95% CI: 0.22-0.32). Based on IDF definition, the MetS prevalence rates in women and men were0.39 (95% CI: 0.19-0.59) and 0.20 (95% CI: 0.10-0.29), respectively.
Conclusion: The findings showed a high prevalence of metabolic syndrome in Iran, especially in women, which increases with age in both sexes. Health care providers and policy makers need to find solutions to reduce MetS risk in the society.
© 2014, Journal of Kermanshah University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
The references of this article is available on PDF